
Reset all filters
01 3Qulipta
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 158
2021 Revenue in Millions : 0
Growth (%) : New Launch in 2022
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 408
2022 Revenue in Millions : 158
Growth (%) : 158
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 658
2023 Revenue in Millions : 408
Growth (%) : 61